CampbellBC.Hyperacute ischemic stroke care-current treatment and future directions. Int J Stroke2024; 19: 718–726.
2.
MuirKW.Should we switch to tenecteplase for all ischemic strokes? evidence and logistics. Int J Stroke2025; 20: 261–267.
3.
QiuZLiFSangH, et al. Intravenous tenecteplase before thrombectomy in stroke. N Engl J Med2025. Epub ahead of print 21 May 2025. DOI: 10.1056/NEJMoa2503867.
4.
AndersonCSSummersDOuyangM, et al. Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferiority trial. The Lancet. Epub ahead of print 21 May 2025. DOI: 10.1016/S0140-6736(25)00549-5.
5.
FeiginVLBraininMNorrvingB, et al. World stroke organization: global stroke fact sheet 2025. Int J Stroke2025; 20: 132–144.
6.
NasreldeinAAsyrafWNguyenTN, et al. Global challenges in the access of endovascular treatment for acute ischemic stroke (global MT access). Int J Stroke2025; 20: 660–668.
7.
LiMZhengLNieX, et al. Endovascular therapy for large ischemic stroke in directly admitted versus transferred patients: a secondary analysis. Int J Stroke2025; 20: 731–740.
8.
AsifKSMitraAOrtega-GutierrezS, et al. Geo-spatial analysis of acute ischemic stroke reperfusion treatment in India: an assessment of distribution and access to centers. Int J Stroke2025; 20: 708–720.
9.
ShiomiYMiwaKJensenM, et al. Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy: post hoc analysis of the EOS individual participant data. Int J Stroke2025; 20: 679–686.
10.
SalimHAYedavalliVMilhemF, et al. Efficacy and safety of mechanical thrombectomy in distal medium middle cerebral artery occlusion ischemic stroke patients on low-dose aspirin. Int J Stroke2025; 20: 669–678.
11.
GharaibehKAladamatNMierzwaAT, et al. Blood pressure after successful endovascular therapy: a systematic review and meta-analysis of randomized control trials. Ann Neurol2024; 95: 858–865.
12.
YunJKimKHJungJW, et al. Effects of blood pressure lowering in patients treated with intravenous thrombolysis before endovascular thrombectomy. Int J Stroke2025; 20: 696–707.
13.
TaoCLiRZhuY, et al. Endovascular treatment for acute basilar artery occlusion: a multicenter randomized controlled trial (ATTENTION). Int J Stroke2022; 17: 815–819.
14.
LiCWuCWuL, et al. BAOCHE investigators. basilar artery occlusion Chinese endovascular trial: protocol for a prospective randomized controlled study. Int J Stroke2022; 17: 694–697.
15.
MarkusHS.Posterior circulation stroke from diagnosis to management, including recent data on thrombectomy for basilar artery occlusion from the BAOCHE and ATTENTION trials. Int J Stroke2022; 17: 712–713.
16.
RenúAMillánMSan RománL, et al. Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke. JAMA2022; 327: 826–835.
17.
YangBBaiXYiT, et al. Intra-arterial alteplase thrombolysis after successful thrombectomy for acute ischemic stroke in the posterior circulation (IAT-TOP): study protocol and rationale. Int J Stroke2025; 20: 750–755.
18.
Parry-JonesARKrishnamurthiRZiaiWC, et al. World Stroke Organization (WSO): global intracerebral hemorrhage factsheet 2025. Int J Stroke2025; 20: 145–150.
19.
CRASH-3 Trial Collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. The Lancet2019; 394: 1713–1172.
20.
SpriggNFlahertyKAppletonJP, et al. TXA for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomized, placebo-controlled, phase 3 superiority trial. The Lancet2018; 391: 2107–2115.
21.
PandianJDPhillipsAVermaSJ, et al. Indian trial of tranexamic acid in spontaneous intracerebral hemorrhage study protocol. Int J Stroke2025; 20: 756–762.
22.
JumahAMohamedelkhairAElfahamA, et al. Predicting stroke in patients with infective endocarditis: a systematic review and meta-analysis of risk factors. Int J Stroke2025; 20: 646–659.
23.
RapilloCMGiuricinASartiC, et al. Prevalence of carotid plaques with high-risk features in embolic stroke of undetermined source: systematic review and meta-analysis. Int J Stroke2025; 20: 636–645.
